CONTACT
+91 80 2808 2808
info@biocon.com
Biocon  /  Businesses  /  Generics  /  Manufacturing Operations

MANUFACTURING OPERATIONS

Overview

Biocon currently has 5 state-of-the-art facilities across Bangalore, Hyderabad and Visakhapatnam in India that manufacture high quality products with reliability and efficiency.

Biocon’s unique technological strengths across large scale world-class manufacturing facilities supported by a strong quality culture and a consistent track record of regulatory compliance have enabled us to efficiently manufacture and supply differentiated and complex products and emerge as a strong global player. Our API and formulation manufacturing facilities together enable our vertical integration strategy and ensure supply reliability.

Biocon currently has 5 state-of-the-art facilities across Bangalore, Hyderabad and Visakhapatnam in India that manufacture high quality products with reliability and efficiency. In addition to our in-house manufacturing sites, strategic partnerships with global CMOs are leveraged to add value to our partners.

Our API manufacturing facilities leverage complex technology platforms that range from microbial fermentation, chromatographic purification, chemical synthesis, peptide synthesis and HPAPIs.

Our API facilities are equipped with a wide range of equipment, to handle fermentation and chemical processes, including but not limited to fermenters (upto 100 KL scale), high-pressure liquid chromatography columns (upto 1200 mm), extractors, decanters, filtration units (microfiltration/ultrafiltration/nano-filtration), cryogenic reactors, hydrogenators, centrifuges, crystallizers, lyophilizers and dryers.

Peptide facility with different scales of peptide synthesizers and supporting unit operations

Dedicated facility for potent molecules with barrier technology (Isolators)

Our formulation manufacturing infrastructure helps us manufacture potent and non-potent oral solid dosage forms as well as parenteral dosage forms such as lyophilized powders, liquid vials, cartridges, devices and pre-filled syringes.

Our state-of-the-art oral solid facility is equipped with similar unit operations like the R&D facility; including but not limited to wet/dry granulators, fluidised bed dryer, blender, compressors, capsule and blister packing machines; which ensures seamless scale-up from R&D to cGMP facility.

We have also triggered a state-of-the-art injectable drug product facility catering to global regulatory standards

KEY MANAGEMENT TEAM
PRODUCTS
PRESS RELEASES
CORPORATE GOVERNANCE
WORKING WITH US
Share